|
1
|
Ferreri AJ, Campo E, Seymour JF, Willemze
R, Ilariucci F, Ambrosetti A, Zucca E, Rossi G, López-Guillermo A,
Pavlovsky MA, et al: Intravascular lymphoma: Clinical presentation,
natural history, management and prognostic factors in a series of
38 cases, with special emphasis on the ‘cutaneous variant’. Br J
Haematol. 127:173–183. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Ferreri AJ, Dognini GP, Govi S, Crocchiolo
R, Bouzani M, Bollinger CR, D'Incan M, Delaporte E, Hamadani M,
Jardin F, et al: Can rituximab change the usually dismal prognosis
of patients with intravascular large B-cell lymphoma? J Clin Oncol.
26:1–5136. 2008. View Article : Google Scholar
|
|
3
|
Sawamoto A, Narimatsu H, Suzuki T,
Kurahashi S, Sugimoto T and Sugiura I: Long-term remission after
autologous peripheral blood stem cell transplantation for relapsed
intravascular lymphoma. Bone Marrow Transplant. 37:233–234. 2006.
View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Swerdlow SH, Campo E, Harris NL, Jaffe ES,
Pileri SA, Stein H, Thiele J and Vardiman JW: WHO classification of
tumours of haematopoietic and lymphoid tissue. Fourth. Geneva:
World Health Organization; 2008
|
|
5
|
Mahasneh T, Harrington Z, Williamson J,
Alkhawaja D, Duflou J and Shin JS: Intravascular large B-cell
lymphoma complicated by invasive pulmonary aspergillosis: A rare
presentation. Respirol Case Rep. 2:67–69. 2014.PubMed/NCBI
|
|
6
|
Anila KR, Nair RA, Koshy SM and Jacob PM:
Primary intravascular large B-cell lymphoma of pituitary. Indian J
Pathol Microbiol. 55:549–551. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Ponzoni M and Ferreri AJ: Intravascular
large B cell lymphoma: Widespread but not everywhere. Acta
Haematol. 131:16–17. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Khalifa KA, Alkilani AA, Ismail H and
Soliman MA: Evaluation of some biochemical markers as prognostic
factors in malignant lymphoma. J Egypt Natl Canc Inst. 20:47–54.
2008.PubMed/NCBI
|
|
9
|
Sinha N, Lantigua L, Niazi M and
Diaz-Fuentes G: An elderly lady with fever of unknown etiology and
severe pulmonary hypertension: Intravascular lymphoma-an elusive
diagnosis. Case Rep Med. 2013:1537982013. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Chinen Y, Nakao M, Sugitani-Yamamoto M,
Kiyota M, Horiike S, Kuroda J and Taniwaki M: Intravascular B-cell
lymphoma with hypercalcemia as the initial presentation. Int J
Hematol. 94:567–570. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Fung KM, Chakrabarty JH, Kern WF,
Magharyous H, Gehrs BC and Li S: Intravascular large B-cell
lymphoma with hemophagocytic syndrome (Asian variant) in a
Caucasian patient. Int J Clin Exp Pathol. 5:448–454.
2012.PubMed/NCBI
|
|
12
|
Yu H, Chen G, Zhang R and Jin X: Primary
intravascular large B-cell lymphoma of lung: A report of one case
and review. Diagn Pathol. 7:702012. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Seam P, Juweid ME and Cheson BD: The role
of FDG-PET scans in patients with lymphoma. Blood. 110:3507–3516.
2007. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Wagner T, Brechemier D, Dugert E, Le
Guellec S, Julian A, Hitzel A and Beyne-Rauzy O: Diffuse pulmonary
uptake on FDG-PET with normal CT diagnosed as intravascular large
B-cell lymphoma: A case report and a discussion of the causes of
diffuse FDG uptake in the lungs. Cancer Imaging. 23:7–12. 2012.
View Article : Google Scholar
|
|
15
|
Nishizawa T, Saraya T, Ishii H and Goto H:
Antemortem diagnosis with multiple random skin biopsies and
transbronchial lung biopsy in a patient with intravascular large
B-cell lymphoma, the so-called Asian variant lymphoma. BMJ Case
Rep. 2014:pii: bcr20132026612014. View Article : Google Scholar
|
|
16
|
Chen Y, Ding C, Lin Q, Yang K, Li Y and
Chen S: Primary intravascular large B-cell lymphoma of the lung: A
review and case report. J Thorac Dis. 6:E242–E245. 2014.PubMed/NCBI
|
|
17
|
Takahashi H, Tomita N, Yokoyama M, Tsunoda
S, Yano T, Murayama K, Hashimoto C, Tamura K, Sato K and
Ishigatsubo Y: Prognostic impact of extranodal involvement in
diffuse large B-cell lymphoma in the rituximab era. Cancer.
118:4166–4172. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Shimada K, Matsue K, Yamamoto K, Murase T,
Ichikawa N, Okamoto M, Niitsu N, Kosugi H, Tsukamoto N, Miwa H, et
al: Retrospective analysis of intravascular large B-cell lymphoma
treated with rituximab-containing chemotherapy as reported by the
IVL study group in Japan. J Clin Oncol. 26:3189–3195. 2008.
View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Ferreri AJ, Campo E, Ambrosetti A,
Ilariucci F, Seymour JF, Willemze R, Arrigoni G, Rossi G,
López-Guillermo A, Berti E, et al: Anthracycline-based chemotherapy
as primary treatment for intravascular lymphoma. Ann Oncol.
15:1215–1221. 2004. View Article : Google Scholar : PubMed/NCBI
|
